Form 4: Aspen Aerogels Director James E. Sweetnam Reports Equity Grant

Director James E. Sweetnam reports receiving restricted shares and stock options from Aspen Aerogels as part of the annual equity grant for non-employee directors.

Summary

• James E. Sweetnam, a director of Aspen Aerogels, reported the acquisition of 1,898 shares of common stock and 1,657 stock options on May 30, 2024.
• The shares were granted as restricted stock, and the options were granted as part of the annual equity grant for non-employee directors.
• The restricted shares and options will vest on the earlier of May 30, 2025, or the day before the 2025 annual meeting of stockholders.
• Following the transaction, Sweetnam directly owns 15,581 shares of Aspen Aerogels common stock and 1,657 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices, aligning director interests with shareholders.

Positives

• The equity grants align the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the equity grants.

Industry Context

This filing is a routine disclosure related to director compensation, which is a common practice in publicly traded companies to attract and retain qualified board members.

Stakeholder Impact

• Shareholders: The equity grants align the director's interests with those of the shareholders.
• Employees: The grants are part of the overall compensation structure, which can impact employee morale and retention.

Key Dates